AXL could affect cytotoxic immune response against tumors by reducing the expression of intercellular adhesion molecule 1 (ICAM1) and UL16 binding protein 1 (ULBP1) in mesenchymal human lung cancer cells. This evidence concerns the gene ULBP1 and lung carcinoma.